Q3 FY26 · Ended Sep 30, 2026 · View SEC filing
Profit outran operations on a share stake
Net income rose 64.6% while operating income rose 7.7%, so most of the jump came from below the operating line.
It brings in 48.3% of sales but a far larger share of operating income, so its margin sets the company's profit path.
Free cash flow was $230M against $1.37B of net income, partly because the Solventum stake gain brought in no cash.
Operating margin rose 1.46 points only because last year's divestiture loss did not recur; selling and administrative costs grew 12.3%.
Unlock the financial breakdown, competitive insights, historical trends and founder playbook, plus research across the company library.
Free CXProWealth membership required
Business Lens describes 3M from its own filings with the SEC. It is not a view on its shares, a target, or advice to buy, sell or hold anything; figures are as filed and may be restated by the company later. The filing is linked above.
